Yutaka Nagai
Overview
Explore the profile of Yutaka Nagai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
522
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sato K, Uehara A, Kinoshita S, Nomura I, Yagi M, Tanizaki Y, et al.
Sci Rep
. 2018 Nov;
8(1):16245.
PMID: 30390005
Automated blood cell counters can distinguish cells based on their size and the presence or absence of a nucleus. However, most vertebrates have nucleated blood cells that cannot be counted...
12.
Nagai Y, Nakamoto T, Nakasone T, Taira Y, Aoki Y
Gynecol Oncol Rep
. 2018 Oct;
26:56-59.
PMID: 30302364
•A patient with high-risk choriocarcinoma who had refractory or quiescent/minimally invasive disease.•She was treated with seven lines of chemotherapy and salvage surgeries.•The patient had persistently low hCG levels without evidence...
13.
Takao M, Nagai Y, Ito M, Ohba T
Genes Cells
. 2018 Sep;
23(11):963-973.
PMID: 30220098
Extracellular vesicles (EV) have attracted attention as circulating biomarkers for many diseases, particularly cancer. Conventional immunofluorescence staining has been used for the detection of target antigens on EV by flow...
14.
Kusada T, Toita T, Ariga T, Maemoto H, Hashimoto S, Shiina H, et al.
J Radiat Res
. 2017 Nov;
59(1):67-76.
PMID: 29186565
This study evaluated the oncologic outcomes and complications of cervical cancer patients in terms of CT-based image-guided brachytherapy (IGBT) parameters. Of 68 cervical cancer patients treated with definitive radiotherapy/concurrent chemoradiotherapy,...
15.
Takekuma M, Mori K, Iida T, Kurihara K, Saitou M, Tokunaga H, et al.
Cancer Chemother Pharmacol
. 2017 Aug;
80(4):697-705.
PMID: 28785994
Purpose: This study aimed at evaluating the applicability of the concept of platinum sensitivity to recurrent cervical cancer. Methods: The clinical information of patients with recurrent cervical cancer, who were...
16.
Kinjyo Y, Nagai Y, Toita T, Kudaka W, Ariga T, Shimoji Y, et al.
Br J Radiol
. 2017 Jul;
90(1076):20170241.
PMID: 28707541
Objective: To compare patients with cervical cancer who were primarily treated with concurrent chemoradiotherapy (CCRT) using 20 mg m CDDP for 5 days every 3 weeks with weekly regimens of...
17.
Nakasone T, Nagai Y, Arakaki Y, Kinjyo Y, Aoki Y
Gynecol Oncol Rep
. 2017 Feb;
20:15-17.
PMID: 28217736
•Little is known about the history of cancer patients complicated with IE.•It is very important to do the chemotherapy without delay for choriocarcinoma.•We report a case of choriocarcinoma complicated by...
18.
Oishi S, Kudaka W, Toita T, Ariga T, Nakamoto T, Wakayama A, et al.
Anticancer Res
. 2016 Jun;
36(7):3471-5.
PMID: 27354610
Aim: We report a retrospective evaluation for patients with stage IVB cervical cancer in order to identify survival rates and to improve our current practice. Patients And Methods: We analyzed...
19.
Imoto S, Inamine M, Kudaka W, Nagai Y, Wakayama A, Nakamoto T, et al.
Springerplus
. 2016 Mar;
5:125.
PMID: 26933624
Vulvar cancer is a relatively rare disease. The aim of this study was to investigate prognostic factors in vulvar squamous cell carcinoma patients treated with primary surgery. Forty cases of...
20.
Umayahara K, Takekuma M, Hirashima Y, Noda S, Ohno T, Miyagi E, et al.
Gynecol Oncol
. 2015 Dec;
140(2):253-8.
PMID: 26701414
Objective: A multicenter phase II trial was conducted to assess the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) with weekly cisplatin (CDDP) and paclitaxel (PTX) in patients with locally advanced...